NO - Norway (National level)

Innovation Performance Group (2019) : Strong

Total population (2019) 5328212

Population per km² (2017) 17

Proportion population older 65 year % 17,24%

Regional website

Innovation Norway

University of Bergen


Norway has a population of approximately 5 million people.  As well as being involved in a number of major Initiatives around personalised medicine, Norway has a national strategy for personalised medicine within the health service. The strategy will contribute to development and implementation in the health service in the period 2017-2021.

In collaboration with regional health authorities, the Research Council also published an action plan for research and innovation in personalised medicine. The action plan proposes a number of measures to achieve: Increased interaction, international cooperation, leverage national advantages, increased visibility, more interdisciplinarity and better coordination, reduced barriers to interaction, responsible research and innovation.

Is the region looking for international/European/interregional collaboration opportunities? Yes

Coordinate with ECRIN, NorCRIN , EATRIS

Membership status

Member ICPerMed? no 

Mountain ? > 50 % of surface in mountain areas

Member Euregha? no 

Adriatic-Ionian MacroRegion? no

InnoStars Region? no 

Northern Sparsely Populated Area (NSPA)?  no

PM region according EC? no 

Baltic Sea MacroRegion?  no

S3MedTech region? no 

Danube MacroRegion? no

S3P4PM region? no 

Alpine MacroRegion? no

Regions4PM region? no

S3ClusSport member? no 

Central Europe? no

MedTech4Europe? no

Council of European BioRegions (CEBR)? no

1M+Genome initiative? member

European Regions Research & Innovation Network (ERRIN)?  no

Vanguard Initiative? no

ERAPerMed? yes, The Research Council of Norway, (RCN)

Policy documents

  1. National:  Strategi for persontilpasset medisin i helsetjenesten  

  2. National: Handlingsplan for forskning og innovasjon innenfor persontilpasset medisin (2018–2021)  

  3. Industry National: Dette er persontilpasset medisin

  4. Nordic NOK 165 million initiative to boost research and innovation in personalised medicine 

Topics covered by policies : Medical research and innovation (-omics, biomarkers, diagnostics, etc.); Education, training and skill development; Prediction and prevention; ICT/genomics, health, lifestyle data(infrastructure); Electronic and mobile health solutions; Public awareness, patient participation with respect to Personalised Medicine/Personalised Health

Funding for a dedicated programme related to personalised medicine; Education and training, linked to personalised medicine

Major initiatives

  1. BigMed

  2. ERA PerMed AML_PM 

  3. Horizon 2020 AMLvaccin  

  4. University of Bergen  biobank/genome sequencing infrastructure/super computer/strategic research centra

  5. Haukeland University Hospital, Helse Bergen HF  biobank/genome sequencing infrastructure/super computer/strategic research centra

  6. NorCRIN Trial infrastructure

  7. ERA PerMed AML_PM

  8. Horizon 2020 AMLvaccin

  9. Member European '1+ Million Genomes' Initiative 

  10. Digital Innovation Hubs:

Is the region represented in: Horizon2020; Regional Smart Specialisation Strategy Platforms/Partnerships (RIS3); EIT Health/InnoStars/Regional Innovation Scheme (RIS); other?


  1. Horizon2020

  2. EUREKA/Eurostars/COSME

Self evaluation

General perception of the implementation level of PM in the region - Low

Rate of the need for developing and implementing PM in the region - Very High

Rate of the need for increasing support/funding for PM activities in the region - High

Rate of the need for increasing the capacity of PM skills in the region - High

Rate of the genomics literacy of the citizens in the region - Low

Rate of the need for increasing interregional collaboration in PM - Very High

Image attribution

By Rob984 - Derived from File:Germany on the globe (Germany centered).svg, CC BY-SA 4.0,

  • LinkedIn
  • Facebook
  • Twitter
  • YouTube

This project has received funding from the European Union’s Horizon 

2020 research and innovation programme under grant agreement No 825046

The project is co-ordinated by Department Economy, Science and Innovation (EWI) of the Flemish Government.

Department Economy, Science and Innovation - Koning Albert II-laan 35 1030 Brussels, Belgium